Medesis Pharma
  • en
  • fr
  • Corporate
    • General presentation
    • Historical
    • Governance
    • Supervisory board
    • Scientific Advisory board
  • Technology
    • Description
    • Advantages
    • Historical
  • Pipeline
  • Clinical
    • Alzheimer’s disease
  • Pre-clinical
    • Neurology
    • Cancer
    • Nuclear
  • Investors
    • Share information
    • Press release
    • Reports and documents
    • Regulated information
    • General Meetings
    • Agenda & Contact
  • Scientific publications
  • Contacts
Select Page
Alzheimer: What if Medesis Pharma had the right key ?

Alzheimer: What if Medesis Pharma had the right key ?

by Patrick Maurel | Oct 10, 2017 | Press news

AUDIO EDITION : the Montpellier biotech publishes very interesting results with its lipidic microemulsion of Lithium, NP03.   Jean-Claude Maurel,CEO of Medesis Pharma. A preclinical study published by the team of Professor Claudio Cuello, MgGill University Montreal...

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse_EN

by Patrick Maurel | Oct 4, 2017 | Non classé

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease   Pouladi MA, Brillaud E, Xie Y, Conforti P, Graham RK, Ehrnhoefer DE, Franciosi S, Zhang W, Poucheret P, Compte E, Maurel JC, Zuccato C, Cattaneo E,...

Systemic Delivery of siRNA Down Regulates Brain Prion Protein_EN

by Patrick Maurel | Oct 4, 2017 | Non classé

Systemic Delivery of siRNA Down Regulates Brain Prion Protein and Ameliorates Neuropathology in Prion Disorder   Lehmann S, Relano-Gines A, Resina S, Brillaud E, Casanova D, Vincent V, Hamela C, Poupeau S, Laffont M, Gabelle A, Delaby C, Belondrade M, Arnaud JD,...

Phase behavior of reverse microemulsions based on Peceol®_EN

by Patrick Maurel | Oct 3, 2017 | Non classé

Phase behavior of reverse microemulsions based on Peceol®   Mouri A, Diat O, El Ghzaoui A, Bauer C, Maurel JC, Devoisselle JM, Dorandeu C, Legrand P   The phase diagram of the four component system Peceol®/lecithin/ethanol/water was studied at 25 °C and at a...

Water solubilization capacity of pharmaceutical microemulsions_EN

by Patrick Maurel | Oct 3, 2017 | Non classé

Water solubilization capacity of pharmaceutical microemulsions based on Peceol®, lecithin and ethanol   Mouri A, Diat O, Dan Lerner A, El Ghzaoui A, Ajovalasit A, Dorandeu C, Maurel JC, Devoisselle JM, Legrand P   Biocompatible microemulsions composed of...
« Older Entries

Recent Posts

  • Alzheimer’s disease
  • We develop new drugs to preserve life
  • Investors
  • Medesis Pharma & Transgene prolongent leur accord de recherche collaborative
  • NanoSIRNA

Recent Comments

    Archives

    • August 2021
    • June 2021
    • January 2021
    • November 2020
    • March 2020
    • July 2019
    • October 2017
    • September 2017
    • July 2017
    • June 2017

    Categories

    • Banner in one
    • Clinical stage products
    • In one
    • Investors
    • Non classé
    • Preclinical stage product
    • Press news
    • Research
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Facebook
    • X
    • Instagram
    • RSS

    Designed by Elegant Themes | Powered by WordPress

    Manage Cookie Consent
    We use cookies to optimize our website and our service. Cookie Policy
    Functional Always active
    The storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication on an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Marketing
    The technical storage or access that is used exclusively for statistical purposes. Technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance by your ISP, or additional third-party records, information stored or retrieved for this purpose alone generally cannot be used to identify you.
    Marketing
    Storage or technical access is required to create user profiles to send advertising, or to track the user across one or multiple websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    Personalize
    {title} {title} {title}